Clinical trial
A Phase I Study of Docetaxel Plus 5-FU, Cisplatin and Leucovorin in Patients With Advanced Solid Tumors
NCT00004913 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Study of Docetaxel Plus 5-FU, Cisplatin and Leucovorin in Patients With Advanced Solid Tumors
- Lead sponsor
- Northwestern University
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 31, 2000
- Completion date
- May 31, 2002
- Enrollment
- Not reported
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
unspecified adult solid tumor, protocol specific